© 2021 MJH Life Sciences™ and Formulary Watch. All rights reserved.
Multiple sclerosis (MS) is a neurologic disorder of chronic inflammation and demyelination of the central nervous system. Several additional agents, including oral products, are now under investigation for the future treatment of MS.